Patents by Inventor Nathan E. HALL

Nathan E. HALL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230242992
    Abstract: This invention relates generally to systems and methods of predicting the likelihood of cancer progression or recurrence. More particularly, the present invention relates to systems and methods of identifying nucleic acid mutation signatures that correlate with the likelihood of cancer recurrence or progression, and methods of using such signatures.
    Type: Application
    Filed: June 1, 2021
    Publication date: August 3, 2023
    Inventors: Robyn A. LINDLEY, Nathan E. HALL, Jared MAMROT
  • Publication number: 20200370124
    Abstract: This invention relates generally to systems and methods for predicting the efficacy of a cancer therapy in a subject. The systems and methods of the disclosure can be used, for example, to determine a therapy indicator for use in assessing responsiveness to cancer therapy, to determine whether a subject is likely to respond to a new cancer therapy, and/or to determine whether a subject is likely to continue to respond to current cancer therapy.
    Type: Application
    Filed: November 16, 2018
    Publication date: November 26, 2020
    Applicant: GMDx Co Pty Ltd.
    Inventors: Nathan E. HALL, Jared MAMROT, Robyn A. LINDLEY